See how Mesa is working hard to keep you compliant with new CDC requirements for Vaccines for Children
|
|
|
|
|
Dedicated Project Management – One territory representative for streamlined and efficient service.
Mesa Labs would like to invite our customers and friends to visit us at the upcoming 2017 Specialty Pharmacy Summit in Las Vegas, Nevada, April 30 – May 3. This annual event is the largest U.S. conference for the specialty pharmacy industry. It welcomes thousands of attendees including senior executives and key decision makers from…
Details
Mesa Labs would like to invite our customers and friends to visit us at the upcoming HCP Hospital Pharmacy Spring Conference in Los Angeles, California, May 1-3. HCP brings providers and suppliers together through industry-specific conferences, such as Hospital Pharmacy. The conference is designed to provide the optimum environment for networking and building relationships between…
Details
As you may have heard, the Checkpoint and AmegaView monitoring systems are reaching their End of Life. This provides the opportunity for our customers to upgrade to the new, modern, customizable, web-based ViewPoint Monitoring System that will serve your needs for years to come. These upgrades allow you to be able to function in today’s…
Details
Mesa is proud to host Vizient in a three-part webinar series discussing temperature monitoring best practices, the CDC’s Vaccines for Children, and choosing the best monitoring system for your needs. Read below for more information on each webinar. Register today! Webinar #1 3/22 Webinar @ 1:30pm – 2:30pm CDT Title: “Top 10 Temperature Monitoring…
DetailsMesa has created a service network specifically suited to provide in-house services to our customers. Whether your needs call for equipment repair, calibration or process validation, Mesa’s Global Services team is uniquely qualified to provide you with specialized service, expert protocol development and execution and complete validation services to suit every need.
When looking for a monitoring program, Mesa Labs understands that you are not simply looking for software to monitor your equipment, you are looking for a monitoring partner to help you protect valuable product and archive valuable data. Monitoring systems prove their worth when called into action and the systems from Mesa Labs provide you with extremely effective and efficient alarming systems able to communicate via phone, text and email when conditions drift outside of your defined acceptance ranges.
Paramount to any Continuous Monitoring System are its capabilities when an alarm situation occurs. Varying the alerting by department, piece of equipment, time of day, day of the week, condition parameters, delivery method and escalation protocols can mean the difference between immediate/appropriate action and interaction, and coworker frustration and product loss.
Mesa Labs offers a suite of professional services to maintain its monitoring systems in optimal operating condition. Our personalized services are tailored to guide you in the transition to a fully automated monitoring system following installation. On-going support services are designed to maintain streamlined operations.
-Initial System Installation & Setup
-Transition Period Support & Go-Live Services
-Consulting & Other Professional Services
Mesa Labs has developed a complete validation protocol to meet rigorous FDA and other regulatory requirements. Our comprehensive Installation, Operational, and Performance Qualification (IQ/OQ/PQ) protocol validates compliance with the FDA 21 CFR Part 11 and facilitates our customer’s ability to meet GxP guidelines and 21 CFR Parts 210/211 requirements. Test execution is documented in the protocol test pages using Good Documentation Practices. Upon completion of the protocol, the client receives a detailed summary report; the executed protocol and all raw data, and all supporting documentation in a single turnover binder. Any deviations encountered during testing are identified and resolved prior to final document delivery to the client.
